Skip to main content

Table 3 Site summary for modulation complexity scores and gamma passing rates. The data is presented as mean values ± SD

From: Initial characterization, dosimetric benchmark and performance validation of Dynamic Wave Arc

 

DWA

VMATCDR

 
 

mean ± SD

mean ± SD

p-value

Prostate

MCS

0.46 ± 0.02

0.49 ± 0.06

p = 0.42

Æ”-index (%)

98.17 ± 0.86

98.4 ± 1.71

p = 0.97

Oligometastatic cases

MCS

0.28 ± 0.05

0.32 ± 0.05

p = 0.03

Æ”-index (%)

98.72 ± 1.13

98.42 ± 1.42

p = 0.08

Centrally- located NSCLC

MCS

0.33 ± 0.07

0.35 ± 0.09

p = 0.34

Æ”-index (%)

99.2 ± 0.91

98.54 ± 1.83

p = 0.96

LAPC

MCS

0.46 ± 0.04

0.44 ± 0.04

p = 0.29

Æ”-index (%)

98.1 ± 0.74

98.20 ± 0.70

p = 0.80

  1. Abbreviations: MCS, modulation complexity scores; Æ” (3 %/3 mm), index gamma passing rate representing the agreement score between calculated and measured dose distributions; p-value, statistical output of the student t-test